确定原发性硬化性胆管炎患者的治疗机会窗:胚胎学及炎症性肠病与免疫介导肝损伤重叠
本文综述近期流行病学观察,提出原发性硬化性胆管炎(PSC)与炎症性肠病(IBD)及自身免疫性肝炎(AIH)的重叠可能代表同一PSC临床病理通路的不同表现,呈年龄依赖性。作者推测所有PSC可能起源于「早期PSC-IBD-AIH」重叠,并提出针对胚胎憩室来源组织的「憩室自身免疫」假说,强调开发治疗机会窗的重要性。
要点
- PSC常(60%-90%的病例)与IBD相关(PSC-IBD),较少与AIH相关(PSC-AIH或AIH重叠障碍)。
- PSC-IBD和PSC-AIH重叠似乎代表同一PSC临床病理通路的不同方面,并以年龄依赖的方式表现。
- 作者推测所有PSC可能起源于复杂的「早期PSC-IBD-AIH」重叠,并提出「憩室自身免疫」假说。
核心结论
- PSC-IBD和PSC-AIH重叠似乎代表同一PSC临床病理通路的不同方面,并以年龄依赖的方式表现。
- 作者推测所有PSC可能起源于复杂的「早期PSC-IBD-AIH」重叠,其中PSC沿个体化终生连续体定义独特且可变相关的AIH和IBD成分。
- 作者推测针对胚胎盲肠和肝憩室来源组织的独特「憩室自身免疫」可能是该联合综合征的起源。
- 该假说为PSC表现和进展的年龄依赖性变异提供了解释,并强调在目前被认为不可逆的疾病过程中存在「治疗缓解的发育机会窗」的概念。
研究设计与样本
- 本文为综述,回顾近期流行病学观察并提出假说。
主要发现
- PSC是一种病因不明的肝内和肝外胆管自身免疫性疾病,呈可变进展并导致纤维化。
- PSC常(60%-90%的病例)与IBD相关(PSC-IBD),较少与AIH相关(PSC-AIH或AIH重叠障碍)。
- 肝病学家和胃肠病学家常将这些合并疾病视为与孤立经典形式截然不同。
- PSC-IBD和PSC-AIH重叠似乎代表同一PSC临床病理通路的不同方面,并以年龄依赖的方式表现。
- 作者推测所有PSC可能起源于复杂的「早期PSC-IBD-AIH」重叠,其中PSC沿个体化终生连续体定义独特且可变相关的AIH和IBD成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary sclerosing cholangitis (PSC) is a variably progressive, fibrosis-causing autoimmune disorder of the intrahepatic and extrahepatic bile ducts of unclear etiology. PSC is commonly (in 60%-90% of cases) associated with an inflammatory bowel disease (IBD) like PSC-IBD and less commonly with an autoimmune hepatitis (AIH) like PSC-AIH or AIH-overlap disorder. Hepatologists and Gastroenterologists often consider these combined conditions as distinctly different from the classical forms in isolation. Here, we review recent epidemiologic observations and highlight that PSC-IBD and PSC-AIH overlap appear to represent aspects of a common PSC clinico-pathological pathway and manifest in an age-of-presentation-dependent manner. Particularly from the pediatric experience, we hypothesize that all cases of PSC likely originate from a complex "Early PSC"-"IBD"-"AIH" overlap in which PSC defines the uniquely and variably associated "AIH" and "IBD" components along an individualized lifetime continuum. We speculate that a distinctly unique, "diverticular autoimmunity" against the embryonic cecal- and hepatic diverticulum-derived tissues may be the origin of this combined syndrome, where "AIH" and "IBD" variably commence then variably fade while PSC progresses with age. Our hypothesis provides an explanation for the age-dependent variation in the presentation and progression of PSC. This is critical for the optimal targeting of studies into PSC etiopathogenesis and emphasizes the concept of a "developmental window of opportunity for therapeutic mitigation" in what is currently recognized as an irreversible disease process. The discovery of such a window would be critically important for the targeting of interventions, both the administration of current therapies and therapeutic trial planning.
引用
- Kellermayer R, Carbone M, Horvath TD, et al. Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune-mediated liver injury. Hepatology. 2024. PMID: 38743006. doi:10.1097/HEP.0000000000000926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。